Castle Biosciences COO Kristen Oelschlager reports disposal of common shares worth $138,510.72
CSTL•Insider share disposal reported
- Castle Biosciences COO Kristen M. Oelschlager sold 4,152 shares on Sep. 1, 2026, at USD 3.38 via option exercise.
- Disposed of 4,152 shares in total on the same day, including 3,952 shares at USD 33.36 and 200 shares at USD 34.02.
- Directly held 13,356 shares following the transactions.
- Separately reported 72,649 shares held indirectly through The Fritz Shorter Trust.
